We are live on
!
Find out more
ZAM
Zeal Asset Management Portfolio holdings
AUM
$39.4M
1-Year Est. Return
38.83%
This Fund
S&P 500
This Quarter
Est. Return
-19.14%
1 Year Est. Return
+38.83%
3 Year Est. Return
-26.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$166M
AUM Growth
-$167M
(-50%)
Cap. Flow
-$98.4M
Cap. Flow
% of AUM
-59.16%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
3
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONC
BeOne Medicines Ltd
ONC
|
+$18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zai Lab
ZLAB
|
+$80.2M |
| 2 |
NBP
NovaBridge Biosciences American Depositary Shares
NBP
|
+$19M |
| 3 |
HUTCHMED
HCM
|
+$17.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 96.27% |
| 2 | Technology | 2.25% |
| 3 | Real Estate | 1.48% |
Similar funds
BGDR
HCM
BEVI
MAM
NLG
KXA
SIP
AMC
Zeal Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Zeal Asset Management held 6 positions worth $166M, down 50% from $333M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Zeal Asset Management withdrew a net $98.4M in Q4 2021, reducing 3 holdings. Its largest reduction was Zai Lab, cutting an estimated $80.2M.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 98% a quarter earlier, followed by Technology and Real Estate.
Against the trend, Zeal Asset Management opened a new position in BeOne Medicines Ltd worth $14.4M.
- Zeal Asset Management's largest Q4 2021 buy was BeOne Medicines Ltd: 53,192 shares worth $14.4M.
- Zeal Asset Management's biggest Q4 2021 reduction was Zai Lab, cutting an estimated $80.2M.
- Zeal Asset Management's ten largest holdings make up 100% of its $166M portfolio in Q4 2021.
- Zeal Asset Management opened 1 new position and closed 0 in Q4 2021.
- Zeal Asset Management's portfolio value fell 50% quarter-over-quarter to $166M.
Based on Zeal Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.